
Pharmacally
IDEFIRIX
Approvals, trial readouts, research and drug safety alerts, interpreted by pharmacists and checked against the primary source.
Latest in IDEFIRIX
Clinical TrialsIdefirix Advances Toward Full EU Approval After Positive PAES ResultsHansa Biopharma reported positive topline results from the European PAES study, confirming the long-term benefit of Idefirix® (imlifidase) in highly sensitized kidney transplant patients.Fact-Checked
Mergers & AcquisitionsHansa Licenses IDEFIRIX Rights to SERB in €115 Million DealHansa Biopharma signed an exclusive licensing agreement with SERB for the development and commercialization of IDEFIRIX across Europe and MENA.Fact-Checked
Explore more
Health TidingsIndustry, pipeline and company news.
RegulatoryApprovals, policy and agency decisions.
ResearchPeer-reviewed studies and scientific breakthroughs.
Drug FinderLook up any drug: uses, dosing and safety.
From the HistoryLandmark moments in pharmaceutical history.
LatestEvery new story, as soon as it is published.